title: Multisite, quality-improvement collaboration to optimise cardiac care in Queensland public hospitals.
abstract: OBJECTIVE
  To evaluate changes in quality of in-hospital care of patients with either acute coronary syndromes (ACS) or congestive heart failure (CHF) admitted to hospitals participating in a multisite quality improvement collaboration.
  
  
  METHODS
  Before-and-after study of changes in quality indicators measured on representative patient samples between June 2001 and January 2003.
  
  
  METHODS
  Nine public hospitals in Queensland.
  
  
  METHODS
  Consecutive or randomly selected patients admitted to study hospitals during the baseline period (June 2001 to January 2002; n = 807 for ACS, n = 357 for CHF) and post-intervention period (July 2002 to January 2003; n = 717 for ACS, n = 220 for CHF).
  
  
  METHODS
  Provision of comparative baseline feedback at a facilitative workshop combined with hospital-specific quality-improvement interventions supported by on-site quality officers and a central program management group.
  
  
  METHODS
  Changes in process-of-care indicators between baseline and post-intervention periods.
  
  
  RESULTS
  Compared with baseline, more patients with ACS in the post-intervention period received therapeutic heparin regimens (84% v 72%; P < 0.001), angiotensin-converting enzyme inhibitors (64% v 56%; P = 0.02), lipid-lowering agents (72% v 62%; P < 0.001), early use of coronary angiography (52% v 39%; P < 0.001), in-hospital cardiac counselling (65% v 43%; P < 0.001), and referral to cardiac rehabilitation (15% v 5%; P < 0.001). The numbers of patients with CHF receiving beta-blockers also increased (52% v 34%; P < 0.001), with fewer patients receiving deleterious agents (13% v 23%; P = 0.04). Same-cause 30-day readmission rate decreased from 7.2% to 2.4% (P = 0.02) in patients with CHF.
  
  
  CONCLUSIONS
  Quality-improvement interventions conducted as multisite collaborations may improve in-hospital care of acute cardiac conditions within relatively short time frames.
authors.affiliation: Internal Medicine, Princess Alexandra Hospital, Ipswich Road, Brisbane, QLD 4102, Australia. ian_scott@health.qld.gov.au
authors.forename: Ian A
authors.initials: IA
authors.lastname: Scott
authors.forename: Irene C
authors.initials: IC
authors.lastname: Darwin
authors.forename: Kathy H
authors.initials: KH
authors.lastname: Harvey
authors.forename: Andy B
authors.initials: AB
authors.lastname: Duke
authors.forename: Nicholas D
authors.initials: ND
authors.lastname: Buckmaster
authors.forename: John
authors.initials: J
authors.lastname: Atherton
authors.forename: Hazel
authors.initials: H
authors.lastname: Harden
authors.forename: Michael
authors.initials: M
authors.lastname: Ward
mesh_terms: D000368:Aged; D016507:Cardiology Service, Hospital / Q000592:standards*; D017023:Coronary Angiography; D005260:Female; D006333:Heart Failure / Q000175:diagnosis / Q000628:therapy*; D006493:Heparin / Q000627:therapeutic use; D006779:Hospitals, Public / Q000592:standards*; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000175:diagnosis / Q000628:therapy*; D017063:Outcome Assessment, Health Care; D019984:Quality Indicators, Health Care; D011787:Quality of Health Care; D011793:Queensland; D015912:Thrombolytic Therapy
chemical_list: D006493:Heparin